BR112013016690A2 - agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante - Google Patents

agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante

Info

Publication number
BR112013016690A2
BR112013016690A2 BR112013016690A BR112013016690A BR112013016690A2 BR 112013016690 A2 BR112013016690 A2 BR 112013016690A2 BR 112013016690 A BR112013016690 A BR 112013016690A BR 112013016690 A BR112013016690 A BR 112013016690A BR 112013016690 A2 BR112013016690 A2 BR 112013016690A2
Authority
BR
Brazil
Prior art keywords
agent
lactis
inducing
lactic acid
lactis subsp
Prior art date
Application number
BR112013016690A
Other languages
English (en)
Inventor
Daisuke Fujiwara
Kenta JONAI
Tetsu Sugimura
Original Assignee
Kirin Holdings Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Holdings Kk filed Critical Kirin Holdings Kk
Publication of BR112013016690A2 publication Critical patent/BR112013016690A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/061—Addition of, or treatment with, microorganisms
    • A23C19/062—Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)

Abstract

agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante são fornecidos: um agente indutor de produção de interferon contendo bactérias do ácido lático como um ingrediente ativo e capaz de induzir a produção de ifn; um agente imunopotencializador ou um agente preventivo de infecção viral contendo o agente indutor; e um produto de alimento contendo o agente indutor e tendo atividade indutora de ifn, atividade imunopontencializadora, ou atividade protetora contra infecções virais. o agente indutor de produção de ifn contém, como ingredientes ativos, lactococcus garvieae nbrc100934, lactococus lactis subsp. cremoris jcm16167, lactococcus lactis subsp. cremoris nbrc100676, lactococcus lactis subsp. hordniae jcm1180, lactococcus lactis subsp. hordniae jcm11040, lactococcus lactis subsp. lactis nbrc12007, lactococcus lactis subsp. lactis nric1150, lactococcus lactis subsp. lactis jcm5805, lactococcus lactis subsp. lactis jcm20101, leuconostoc lactis nbrc12455, leuconostoc lactis nric1540, pediococcus damnosus jcm5886, ou streptococcus thermophilus ta-45, que é uma cepa de bactérias do ácido lático capaz de ativar células dendríticas plasmocitoides (pdcs) e induzir a produção de ifn.
BR112013016690A 2010-12-28 2011-12-28 agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante BR112013016690A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010293810 2010-12-28
PCT/JP2011/080359 WO2012091081A1 (ja) 2010-12-28 2011-12-28 乳酸菌を含むインターフェロン産生誘導剤

Publications (1)

Publication Number Publication Date
BR112013016690A2 true BR112013016690A2 (pt) 2016-10-04

Family

ID=46383169

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016690A BR112013016690A2 (pt) 2010-12-28 2011-12-28 agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante

Country Status (8)

Country Link
US (6) US20130302380A1 (pt)
EP (1) EP2659898B1 (pt)
JP (3) JP5950827B2 (pt)
AU (1) AU2011350554B2 (pt)
BR (1) BR112013016690A2 (pt)
ES (1) ES2668096T3 (pt)
NZ (1) NZ613335A (pt)
WO (1) WO2012091081A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9861666B2 (en) * 2013-08-12 2018-01-09 Mansel Griffiths Antiviral methods and compositions comprising probiotic bacterial molecules
JP6652331B2 (ja) * 2014-05-30 2020-02-19 キリンホールディングス株式会社 乳酸菌免疫賦活作用増強組成物及び乳酸菌免疫賦活作用増強方法
JP6455920B2 (ja) * 2014-10-31 2019-01-23 キリン株式会社 微生物又はｄｎａの免疫賦活活性を予測する方法
JP6713751B2 (ja) * 2015-10-26 2020-06-24 キリンホールディングス株式会社 抗原に対する特異的な細胞傷害性ｔ細胞（ｃｔｌ）及び抗体産生を増強させる方法
JP6818405B2 (ja) 2015-11-10 2021-01-20 キリンホールディングス株式会社 乳酸菌の免疫賦活作用を増強する方法
EP3424517A4 (en) * 2016-04-04 2019-11-13 Kikkoman Corporation COMPOSITION FOR PROMOTING THE PRODUCTION OF INTERFERON LAMBDA AND METHOD FOR THE PRODUCTION THEREOF
US11389494B2 (en) 2016-09-09 2022-07-19 Kirin Holdings Kabushiki Kaisha Composition for suppressing or improving eye fatigue
JP7154473B2 (ja) * 2017-05-31 2022-10-18 学校法人順天堂 疲労回復用および／または疲労蓄積予防用組成物
US11179425B2 (en) * 2018-01-09 2021-11-23 Microbio Co., Ltd. Method of activating tumor-infiltrating lymphocytes (TILs)
JP6846376B2 (ja) * 2018-03-15 2021-03-24 キリンホールディングス株式会社 皮膚状態改善用組成物
JP2019167327A (ja) * 2018-03-26 2019-10-03 森永乳業株式会社 ビフィドバクテリウム属細菌を有効成分とする、ｉｉｉ型インターフェロン産生促進用組成物
CN108410777A (zh) * 2018-05-08 2018-08-17 西藏高原之宝牦牛乳业股份有限公司 一种嗜热链球菌及其制备方法
CN110468061B (zh) * 2018-05-11 2024-03-08 韩国亿诺生物有限公司 具有预防或治疗癌症的效果的新型菌株
JP6796299B2 (ja) * 2018-05-23 2020-12-09 キッコーマン株式会社 免疫賦活用組成物及びサイトカイン産生促進用組成物
CN112543641A (zh) * 2018-08-09 2021-03-23 龟甲万株式会社 FcεRI的表达抑制用组合物以及FcεRI的表达抑制方法
JP7316802B2 (ja) * 2019-02-19 2023-07-28 雪印メグミルク株式会社 糖吸収促進用組成物
KR102154254B1 (ko) * 2020-04-29 2020-09-09 (주)녹십자웰빙 우수한 면역기능 증진 효과를 갖는 신규한 유산균 및 이를 포함하는 식품조성물, 건강기능성 식품 조성물 및 프로바이오틱스
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
BR112023003812A2 (pt) 2020-09-25 2023-04-04 House Wellness Foods Corp Alimento para animais, composição para aprimorar a produção de il-12, composição para imunoestimulação e composição para bacteriostase
US20240066076A1 (en) 2021-03-11 2024-02-29 Miyarisan Pharmaceutical Co., Ltd. Interferon production promoter
US20240191177A1 (en) * 2021-04-28 2024-06-13 Kirin Holdings Kabushiki Kaisha Growth promoter for lactic acid cocci
KR102404016B1 (ko) * 2021-06-10 2022-06-02 한국식품연구원 락토코커스 락티스 아종 호르드니아에 균주 및 이의 퇴행성 뇌질환에 대한 예방, 개선 또는 치료 용도
WO2023074820A1 (ja) * 2021-10-29 2023-05-04 国立感染症研究所長が代表する日本国 ＳＡＲＳ－ＣｏＶ－２増殖抑制剤
WO2024117116A1 (ja) * 2022-11-29 2024-06-06 キリンホールディングス株式会社 容器詰め無糖飲料
WO2024137494A1 (en) 2022-12-22 2024-06-27 Dow Global Technologies Llc Recyclate polyol dispersion with improved phase stability
WO2024135856A1 (ja) * 2022-12-23 2024-06-27 国立感染症研究所長が代表する日本国 局所投与用の医薬組成物
WO2024195814A1 (ja) * 2023-03-22 2024-09-26 キリンホールディングス株式会社 免疫賦活用組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
JP2000262247A (ja) 1999-03-19 2000-09-26 Asama Kasei Kk 免疫調節剤、免疫調節食品および免疫調節飼料
JP2001046020A (ja) 1999-08-05 2001-02-20 Nichinichi Seiyaku Kk 花粉抗原による鼻および目症状を改善または予防する食品
JP4712289B2 (ja) * 2003-08-26 2011-06-29 株式会社エイ・エル・エイ 免疫促進用組成物
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
JP5177728B2 (ja) * 2003-12-12 2013-04-10 株式会社明治 Ｎｋ細胞活性化剤
JP2006028047A (ja) 2004-07-14 2006-02-02 Kikkoman Corp インターロイキン１２産生促進剤およびその製造法
JP2007117031A (ja) * 2005-10-31 2007-05-17 Nakagaki Gijutsushi Jimusho:Kk インターフェロンガンマ発現誘導作用を有する発酵乳、及び発酵乳製造用種菌
NZ569590A (en) 2007-02-13 2012-02-24 Morinaga Milk Industry Co Ltd Lactic acid bacteria of a species Lactococcus lactis subsp. lactis that promotes the growth of Bilfidobacterium longum
JP2009005123A (ja) 2007-06-22 2009-01-08 Panasonic Corp テレビジョン放送受信装置、およびテレビジョン放送受信方法
JP2009005124A (ja) 2007-06-22 2009-01-08 Funai Electric Co Ltd デジタル放送記録装置
JP5312322B2 (ja) 2007-07-03 2013-10-09 キッコーマン株式会社 インターフェロンβ産生促進剤及びその製造法
EP2169057B1 (en) 2007-07-04 2015-09-30 Kikkoman Corporation Double-stranded rna originating in lactic acid bacterium
FI20075539L (fi) * 2007-07-12 2009-01-13 Valio Oy Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
JP5247120B2 (ja) * 2007-11-02 2013-07-24 雪印メグミルク株式会社 Ｌ−オルニチン含有物の製造方法
US8277857B2 (en) 2008-06-11 2012-10-02 Morinaga Milk Industry Co., Ltd. Method for producing fermented milk
JP4802216B2 (ja) * 2008-06-11 2011-10-26 森永乳業株式会社 ビフィドバクテリウム属菌含有組成物及びビフィドバクテリウム属菌含有組成物の製造方法
JP2009296972A (ja) * 2008-06-16 2009-12-24 Snow Brand Milk Prod Co Ltd 酵素処理チーズ及びその製造方法
US20110189343A1 (en) 2008-06-26 2011-08-04 Hideo Hasegawa Nano-sized lactic acid bacteria
FI20096058A0 (fi) * 2009-10-13 2009-10-13 Valio Oy Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä

Also Published As

Publication number Publication date
US20240226194A1 (en) 2024-07-11
US20130302380A1 (en) 2013-11-14
US20170106028A1 (en) 2017-04-20
EP2659898B1 (en) 2018-03-07
JP5950827B2 (ja) 2016-07-13
EP2659898A1 (en) 2013-11-06
AU2011350554B2 (en) 2015-10-01
WO2012091081A8 (ja) 2012-08-30
US10220060B2 (en) 2019-03-05
US20220105140A1 (en) 2022-04-07
JPWO2012091081A1 (ja) 2014-06-05
US9549956B2 (en) 2017-01-24
NZ613335A (en) 2015-05-29
AU2011350554A1 (en) 2013-07-25
US11224623B2 (en) 2022-01-18
US20140234379A1 (en) 2014-08-21
US20190192584A1 (en) 2019-06-27
JP2017201984A (ja) 2017-11-16
US11944657B2 (en) 2024-04-02
JP2016073314A (ja) 2016-05-12
EP2659898A4 (en) 2014-06-11
JP6598824B2 (ja) 2019-10-30
ES2668096T3 (es) 2018-05-16
AU2011350554A8 (en) 2013-09-05
WO2012091081A1 (ja) 2012-07-05
JP6170190B2 (ja) 2017-07-26

Similar Documents

Publication Publication Date Title
BR112013016690A2 (pt) agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante
Álvarez-Cisneros et al. Antibiotic resistance in lactic acid bacteria
JP2021078504A5 (pt)
Huff et al. Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens
FI3380108T3 (fi) Suunniteltuja bakteerikoostumuksia
MY197900A (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
Power et al. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12
BR112018005195A2 (pt) lactobacillus plantarum lc27, composição farmacêutica para a prevenção ou tratamento de uma ou mais doenças, composição alimentícia para a prevenção ou tratamento de uma ou mais doenças, método de prevenção ou tratamento de uma ou mais doenças, e uso de uma composição que compreende lactobacillus plantarum lc27
DE60316772D1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
JP2014073130A5 (pt)
JP2024075688A (ja) 微生物感染を防ぐための方法および組成物
RU2013114313A (ru) Противокариесные композиции и пробиотики/пребиотики
RU2010147343A (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
WO2018231992A3 (en) METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION
JP2019500056A5 (pt)
Silva et al. Selection of a candidate probiotic strain of Pediococcus pentosaceus from the faecal microbiota of horses by in vitro testing and health claims in a mouse model of Salmonella infection
WO2011050426A3 (en) New strains of lactic acid bacteria and their combinations producing probiotic preparations
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
BR112017028190A2 (pt) Peptídeo, peptídeo peguilado, composição, composição farmacêutica, frasco, solução de desinfecção, método para inibição de crescimento, replicação ou infectividade de um micro- organismo, método para inibição de crescimento bacteriano, método para inibição de replicação viral em uma célula, método para tratamento de uma infecção de micro-organismo em um sujeito e prevenção de uma doença em um sujeito causada por ou associada a uma infecção de micro- organismo, método para inibição de crescimento bacteriano em um sujeito, método para tratamento de uma infecção bacteriana em um sujeito e tratamento de uma doença causada por ou associada a uma infecção bacteriana, método para prevenção de uma doença causada por ou associada a uma infecção bacteriana em um sujeito, método para inibição de replicação viral em um sujeito, método para tratamento de uma infecção viral em um sujeito e tratamento de uma doença causada por ou associada a uma infecção viral em um sujeito, método para prevenção de uma doença causada por ou associada a uma infecção viral em um sujeito, método para desinfecção de um objeto inanimado ou material biológico e superfície inanimada ou superfície biológica
FI20075539A0 (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
WO2010012972A3 (en) Novel bacterial cells and uses thereof
NZ610400A (en) Antimicrobial protein
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/744 (2015.01), A23C 9/123 (2006.01), A23C

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018.

B350 Update of information on the portal [chapter 15.35 patent gazette]